US Opioids Market

ID: MRFR/HC/13077-HCR 100 Pages Rahul Gotadki Last Updated: September 15, 2026
US Opioids Market Research Report: Size, Share, Trend Analysis By Types (Natural Opioids, Semi-Synthetic Opioids, Fully Synthetic Opioids), By Applications (Pain Management, Anesthesia, Cough Suppression, Diarrhea Treatment), By Route of Administration (Oral, Injectable, Transdermal, Topical) and By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Growth Outlook & Industry Forecast 2025 To 2035
US Opioids Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)2.44%
2024 Market Size$ 13.2 Billion
2025 Market Size$ 13.52 Billion
2035 Market Size$ 17.2 Billion
Key Players
Purdue Pharma
Johnson & Johnson
Teva Pharmaceutical Industries
Mylan N.V.
Endo International
Mallinckrodt Pharmaceuticals
Trends
  • Regulatory Changes
  • Technological Integration
  • Public Awareness Campaigns
Opportunities
  • Rising Pain Management Needs
  • Evolving Regulatory Landscape
  • Increased Focus on Addiction Treatment
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Type (USD Billion)
      1. 4.1.1 Natural Opioids
      2. 4.1.2 Semi-synthetic Opioids
      3. 4.1.3 Fully Synthetic Opioids
      4. 4.1.4 Opioid Derivatives
    2. 4.2 Healthcare, BY Route of Administration (USD Billion)
      1. 4.2.1 Oral
      2. 4.2.2 Injectable
      3. 4.2.3 Transdermal
      4. 4.2.4 Rectal
      5. 4.2.5 Nasal
    3. 4.3 Healthcare, BY Therapeutic Application (USD Billion)
      1. 4.3.1 Pain Management
      2. 4.3.2 Cough Suppression
      3. 4.3.3 Diarrhea Treatment
      4. 4.3.4 Anesthesia
    4. 4.4 Healthcare, BY Patient Population (USD Billion)
      1. 4.4.1 Chronic Pain Patients
      2. 4.4.2 Postoperative Pain Patients
      3. 4.4.3 Cancer Patients
      4. 4.4.4 Palliative Care Patients
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Purdue Pharma (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Johnson & Johnson (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Teva Pharmaceutical Industries (IL)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Mylan N.V. (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Endo International (IE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Mallinckrodt Pharmaceuticals (IE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Amgen Inc. (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Boehringer Ingelheim (DE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TYPE
    3. 6.3 US MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    4. 6.4 US MARKET ANALYSIS BY THERAPEUTIC APPLICATION
    5. 6.5 US MARKET ANALYSIS BY PATIENT POPULATION
    6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF HEALTHCARE
    9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
    12. 6.12 HEALTHCARE, BY TYPE, 2024 (% SHARE)
    13. 6.13 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
    14. 6.14 HEALTHCARE, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
    15. 6.15 HEALTHCARE, BY ROUTE OF ADMINISTRATION, 2024 TO 2035 (USD Billion)
    16. 6.16 HEALTHCARE, BY THERAPEUTIC APPLICATION, 2024 (% SHARE)
    17. 6.17 HEALTHCARE, BY THERAPEUTIC APPLICATION, 2024 TO 2035 (USD Billion)
    18. 6.18 HEALTHCARE, BY PATIENT POPULATION, 2024 (% SHARE)
    19. 6.19 HEALTHCARE, BY PATIENT POPULATION, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Billion)
      2. 7.2.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      3. 7.2.3 BY THERAPEUTIC APPLICATION, 2025-2035 (USD Billion)
      4. 7.2.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US US Opioids Market Segmentation

US Opioids Market By Type (USD Billion, 2025-2035)

  • Natural Opioids
  • Semi-synthetic Opioids
  • Fully Synthetic Opioids
  • Opioid Derivatives

US Opioids Market By Route of Administration (USD Billion, 2025-2035)

  • Oral
  • Injectable
  • Transdermal
  • Rectal
  • Nasal

US Opioids Market By Therapeutic Application (USD Billion, 2025-2035)

  • Pain Management
  • Cough Suppression
  • Diarrhea Treatment
  • Anesthesia

US Opioids Market By Patient Population (USD Billion, 2025-2035)

  • Chronic Pain Patients
  • Postoperative Pain Patients
  • Cancer Patients
  • Palliative Care Patients

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.